Reuters logo
BRIEF-Fortress Biotech to develop therapies for traumatic brain injury treatment
November 7, 2016 / 1:33 PM / a year ago

BRIEF-Fortress Biotech to develop therapies for traumatic brain injury treatment

Nov 7 (Reuters) - Fortress Biotech Inc

* Fortress Biotech Inc- formed a new subsidiary company, Cellvation, Inc., to develop therapies for treatment of traumatic brain injury

* Fortress Biotech-Cellvation entered into agreement with university of texas health science center to secure worldwide rights to three programs for tbi

* Fortress Biotech Inc- announced appointment of Frank Taffy as interim chief executive officer Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below